Specificity | Clone | Host Species | Reactive Species | Format | Size | Reviews | Supplier | |
---|---|---|---|---|---|---|---|---|
PCSK9 (214-228) | polyclonal | Goat | human, mouse, rat | affinity purified | 100 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
PCSK9 (N-term) | polyclonal | Rabbit | human | purified | 400 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
PCSK9 (N-term) | polyclonal | Rabbit | human | unconjugated | 100 ul | n/a |
BIORBYT LTD. |
More Info |
PCSK9 (C-terminal) | polyclonal | Rabbit | human | unconjugated | n/a | n/a |
MILLIPORE-SIGMA |
More Info |
PCSK9/Proprotein Convertase 9 | monoclonal | Rabbit | human | affinity purified | 100 µl | n/a |
BOSTER BIO |
More Info |
PCSK9 Reference Ab (Merck patent anti.PCSK9) | monoclonal | n/a | human, mouse | unconjugated | 100 ug | n/a |
BIORBYT LTD. |
More Info |
PCSK9 Reference Ab (Schering patent anti.PCSK9) | monoclonal | n/a | human, mouse | unconjugated | 100 ug | n/a |
BIORBYT LTD. |
More Info |
Alirocumab (PCSK9) - (biosimilar) | monoclonal | Recombinant | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
Frovocimab (PCSK9) - (biosimilar) | monoclonal | Recombinant | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
Lodelcizumab (PCSK9) - (biosimilar) | monoclonal | Recombinant | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
PCSK9, 164-175 | polyclonal | Goat | human | antigen affinity purified | n/a | Review Available |
ST JOHN'S LABORATORY |
More Info |
PCSK9, 214-228 | polyclonal | Goat | human, mouse, rat | antigen affinity purified | n/a | Review Available |
ST JOHN'S LABORATORY |
More Info |
PCSK9, 30-60 | polyclonal | Rabbit | human, mouse, rat | biotin conjugate | n/a | n/a |
ST JOHN'S LABORATORY |
More Info |
PCSK9, 30-60 | polyclonal | Rabbit | human, monkey, mouse, rat | fluorescein (FITC) conjugate | n/a | n/a |
ST JOHN'S LABORATORY |
More Info |
PCSK9, 30-60 | polyclonal | Rabbit | human, monkey, mouse, rat | affinity purified | n/a | n/a |
ST JOHN'S LABORATORY |
More Info |
PCSK9 (C-term) | polyclonal | Rabbit | human | unconjugated | 100 ul, 30 ul | n/a |
BIORBYT LTD. |
More Info |
PCSK9 (C-term) | polyclonal | Rabbit | human | unconjugated | 100 ul, 30 ul | n/a |
BIORBYT LTD. |
More Info |
PCSK9, C-terminal | polyclonal | Rabbit | human, mouse, rat | affinity purified | n/a | n/a |
ST JOHN'S LABORATORY |
More Info |
PCSK9, C-terminal | polyclonal | Goat | human | antigen affinity purified | n/a | Review Available |
ST JOHN'S LABORATORY |
More Info |
PCSK9 (C Terminus) | polyclonal | Goat | n/a | unconjugated | 50 ug | n/a |
BIORBYT LTD. |
More Info |
PCSK9 (C Terminus) | n/a | Goat | human | unconjugated | 100 ug | n/a |
BIORBYT LTD. |
More Info |
PCSK9 (N-term) | polyclonal | Rabbit | human | unconjugated | 100 ul, 30 ul | n/a |
BIORBYT LTD. |
More Info |
PCSK9 Reference Ab | monoclonal | n/a | human | purified | 5 mg, 1 mg, 100 ug, 50 ug | n/a |
BIORBYT LTD. |
More Info |
Tafolecimab (PCSK9) - (biosimilar) | monoclonal | Recombinant | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
Tilvestamab (PCSK9) - (biosimilar) | monoclonal | Recombinant | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |